SCHEMBL14153034

SCHEMBL14153034

N/C(=N\O)c1ccc(-c2cccc(F)c2)cn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K4 O95819 3/20 0.45
▸ CHEK2 O96017 2/20 0.45
▸ TAAR1 Q96RJ0 3/20 0.45
▸ ESR2 Q92731 1/20 0.45
▸ HPGDS O60760 1/20 0.43
▸ F2R P25116 2/20 0.40
▸ FYN P06241 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ KMO O15229 1/20 0.38
▸ CYP11B2 P19099 2/20 0.38
▸ CYP17A1 P05093 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP11B1 P15538 1/20 0.38
▸ PLK4 O00444 1/20 0.38
▸ CHEK1 O14757 1/20 0.38
▸ AURKA O14965 1/20 0.38
▸ DAPK3 O43293 1/20 0.38
▸ CDK1 P06493 1/20 0.38
▸ PIM1 P11309 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14153156 0.87 MAP4K4 (0.44) MAP4K4CHEK2TAAR1ESR2HPGDS
SCHEMBL12572561 0.82 MKNK1 (0.39) MAP4K4NPC1RAB9AGSK3B
SCHEMBL14153055 0.78 TAAR1 (0.55) MAP4K4CHEK2TAAR1ESR2HPGDS
SCHEMBL15913884 0.77 GRM5 (0.55) —
SCHEMBL14153545 0.77 GRM5 (0.55) —
SCHEMBL4731197 0.77 APLNR (0.36) NPC1RAB9AMAPK1
SCHEMBL4548483 0.77 APLNR (0.36) NPC1RAB9AMAPK1
SCHEMBL30639625 0.77 APLNR (0.36) NPC1RAB9AMAPK1
SCHEMBL486067 0.76 KMO (0.59) MAP4K4CHEK2TAAR1ESR2HPGDS
SCHEMBL31137909 0.75 CYP11B2 (0.46) MAP4K4CHEK2TAAR1ESR2HPGDS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012162635-A1 METABOTROPIC GLUTAMATE RECEPTORS 5 MODULATORS AND METHODS OF USE THEREOF SUNOVION PHARMACEUTICALS INC. (US) 2012-11-29 — — WO disclosed
Send feedback